Freeline, Wugen & Jnana Secure EMA PRIME Designations For Novel Treatments

 
• By Neena Brizmohun
  
cell and gene therapy
Freeline is developing a gene therapy for Gaucher disease • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography